Tuesday 21 May 2019 ,
Tuesday 21 May 2019 ,
Latest News
  • HC seeks reports on Rooppur nuke plant irregularities
  • Opposition could be stronger if Fakhrul would join parliament: Quader
  • Khaleda’s health condition ‘dangerous’: BNP
  • Opposition could be stronger if Fakhrul would join parliament: Quader
  • Govt wants economical development of country : PM
  • BNP names Barrister Rumeen for woman’s parliamentary seat
  • SC to clarify its circular over media reporting: Anisul
  • Cabinet reshuffled for quality works: Quader
25 April, 2019 00:00 00 AM
Print

Beximco gets US FDA nod for Cyproheptadine

Staff Reporter, Dhaka
Beximco gets US FDA nod for Cyproheptadine

Beximco Pharma-ceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, yesterday announced that it has received US Food and Drug Administration (FDA) approval for anti-allergy drug Cyproheptadine Hydrochloride Tablet (4 mg).

Cyproheptadine is a generic equivalent to Periactin®Tablets (4 mg) from Merck and Company, Inc. It is an antihistamine used to relieve allergy symptoms such as hives, watery eyes, sneezing and itchy eyes or nose, said a press release.

In August 2016, Beximco Pharma became the first Bangladeshi pharmaceutical company to export medicine to the US market, following the approval of its oral solid dosage facility by the US FDA in June 2015. Cyproheptadine is now Beximco’s seventh Abbreviated New Drug Application (ANDA) approved for the US market, said the release.

Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said, “Cyproheptadine is our seventh product approved for the US market, and with our recent acquisition of eight ANDAs from Sandoz, our US portfolio now stands at 15 products. This approval gives us further confidence that our strategic focus and growing pipeline will strengthen our presence in the world’s largest pharma market.”

Beximco Pharma, leading exporter of pharmaceuticals in Bangladesh, currently has a global footprint in more than 50 countries and has been accredited by leading global regulatory authorities including the US FDA, AGES (EU), TGA (Australia), Health Canada, GCC (Gulf) and TFDA (Taiwan).

 

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 50.5%
No 45.6%
No Comment 3.9%
Most Viewed
Digital Edition
Archive
SunMonTueWedThuFri Sat
01020304
05060708091011
12131415161718
19202122232425
262728293031

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting